6191 - 6200 of 9033 Results
Title
Year
-
OPENTitle: Validating new symptom emergence as a patient-centric outcome measure for PD clinical trialsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107118End Page: 107118Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107118Best OA location URL: https://www.prd-journal.com/article/S1353-8020(24)01130-1/pdfCitation Count: 0
-
OPENTitle: Stearoyl-CoA desaturase inhibition normalizes brain lipid saturation, α-synuclein homeostasis, and motor function in mutant Gba1-Parkinson miceJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 10Issue #: 13Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.188413Best OA location URL: http://insight.jci.org/articles/view/188413/files/pdfCitation Count: 4
-
OPENTitle: Genetic variants and functional pathways associated with resilience to Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 8Start Page: 2561End Page: 2575Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awaa209Best OA location URL: https://academic.oup.com/brain/article-pdf/143/8/2561/37356057/awaa209.pdfCitation Count: 141
- Dopamine is associated with prioritization of reward-associated memories in Parkinson’s disease2020OPENTitle: Dopamine is associated with prioritization of reward-associated memories in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 8Start Page: 2519End Page: 2531Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa182Best OA location URL: https://academic.oup.com/brain/article-pdf/143/8/2519/33773917/awaa182.pdfCitation Count: 20
-
OPENTitle: Multivariate prediction of dementia in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-020-00121-2Best OA location URL: https://escholarship.org/uc/item/5n39b8t8Citation Count: 59
-
OPENTitle: Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MSJournal Name: Clinical BiochemistryPublisher: Elsevier BVVol: 72Issue #:Start Page: 7End Page: 14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.clinbiochem.2019.05.006Best OA location URL: https://doi.org/10.1016/j.clinbiochem.2019.05.006Citation Count: 47
-
OPENTitle: Effect of the mGlu 2 positive allosteric modulator biphenyl‐indanone A as a monotherapy and as adjunct to a low dose of L‐DOPA in the MPTP‐lesioned marmosetJournal Name: European Journal of NeurosciencePublisher: WileyVol: 60Issue #: 9Start Page: 6175End Page: 6184Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ejn.16454Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.16454Citation Count: 3
- The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile2008RESTRICTEDTitle: The Unified Dyskinesia Rating Scale: Presentation and clinimetric profileJournal Name: Movement DisordersPublisher: WileyVol: 23Issue #: 16Start Page: 2398End Page: 2403Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22341Citation Count: 248
- Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset2022RESTRICTEDTitle: Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmosetJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 939Issue #:Start Page: 175429End Page: 175429Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2022.175429Citation Count: 6
-
OPENTitle: Conversion of Quinazoline Modulators from Inhibitors to Activators of β-GlucocerebrosidaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 62Issue #: 3Start Page: 1218End Page: 1230Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.8b01294Best OA location URL: https://doi.org/10.7270/q280562cCitation Count: 26